VRPX logo

Virpax Pharmaceuticals (VRPX) Enterprise Value

Enterprise Value

$4.57 M
-$238.39 K-4.96%

119 min ago


Summary


Performance

VRPX Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherVRPXvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

VRPX Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-5.0%-4.9%-4.9%
1 m1 month+8.5%+8.4%-12.0%
3 m3 months+27.2%+27.1%-44.0%
6 m6 months+84.0%+5.3%-71.9%
ytdytd-17.9%-17.9%-33.3%
1 y1 year+188.1%+15.8%-92.6%
5 y5 years---

VRPX Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-56.8%$4.06 M+12.5%
3 m3-month$11 M-56.8%$2.41 M+89.6%
6 m6-month$11 M-56.8%$1.71 M+166.9%
1 y1-year$11 M-56.8%-$6 M+179.5%
3 y3-year$11 M-56.8%-$17 M+127.7%
5 y5-year$104 M-95.6%-$17 M+127.7%
alltimeall time$104 M-95.6%-$17 M+127.7%

Virpax Pharmaceuticals Enterprise Value History

DateValue
2025
$4.57 M(-17.9%)
2024
$5.56 M(-203.2%)
DateValue
2023
-$5.39 M(-53.9%)
2022
-$11.71 M(-450.5%)
2021
$3.34 M

FAQ

  • What is Virpax Pharmaceuticals enterprise value?
  • What is the all time high enterprise value for Virpax Pharmaceuticals?
  • What is VRPX enterprise value year-to-date change?
  • What is Virpax Pharmaceuticals enterprise value year-on-year change?

What is Virpax Pharmaceuticals enterprise value?

The current enterprise value of VRPX is $4.57 M

What is the all time high enterprise value for Virpax Pharmaceuticals?

Virpax Pharmaceuticals all-time high enterprise value is $104.19 M

What is VRPX enterprise value year-to-date change?

Virpax Pharmaceuticals enterprise value has changed by -$996.96 K (-17.92%) since the beginning of the year

What is Virpax Pharmaceuticals enterprise value year-on-year change?

Over the past year, VRPX enterprise value has changed by +$9.75 M (+188.12%)